Source link : https://newshealth.biz/health-news/semaglutide-for-alzheimers-what-the-evoke-trials-taught-us/
What happens when a promising therapy falls short? Medscape spoke with Jeffrey Cummings, MD, who led the EVOKE trials of the GLP-1 semaglutide for AD, about what the results mean — and what comes next. Medscape Medical News Source link : https://www.medscape.com/viewarticle/semaglutide-alzheimers-disease-what-evoke-trials-taught-us-2026a10006ry?src=rss Author : Publish date : 2026-03-05 09:24:00 Copyright for syndicated content belongs to […]
The post Semaglutide for Alzheimer’s: What the EVOKE Trials Taught Us first appeared on News Health.
—-
Author : News Health
Publish date : 2026-03-05 09:24:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8